B-Disease	0	11	Retinopathy
O	12	14	in
B-Characteristic	15	26	adolescents
O	27	30	and
B-Characteristic	31	36	young
I-Characteristic	37	43	adults
O	44	48	with
B-Disease	49	54	onset
I-Disease	55	57	of
I-Disease	58	65	insulin
I-Disease	65	66	-
I-Disease	66	75	dependent
I-Disease	76	84	diabetes
O	85	87	in
B-Characteristic	88	97	childhood
O	97	98	.

B-Anatomy	100	107	Retinal
O	108	115	studies
O	116	120	were
O	121	125	done
O	126	128	in
O	129	132	181
O	133	146	postpubescent
O	146	147	,
B-Disease	148	155	insulin
I-Disease	155	156	-
I-Disease	156	165	dependent
I-Disease	166	174	diabetic
O	175	183	patients
O	184	187	who
O	188	197	developed
B-Disease	198	206	diabetes
B-Characteristic	207	213	before
I-Characteristic	214	217	the
I-Characteristic	218	221	age
I-Characteristic	222	224	of
I-Characteristic	225	227	20
O	227	228	.

B-Anatomy	229	236	Retinal
O	237	244	studies
O	245	253	included
O	254	260	serial
B-Diagnostic_tool	261	267	direct
I-Diagnostic_tool	268	283	ophthalmoscopic
I-Diagnostic_tool	284	296	examinations
O	296	297	,
B-Diagnostic_tool	298	310	stereoscopic
I-Diagnostic_tool	311	317	fundus
I-Diagnostic_tool	318	329	photography
O	330	333	and
B-Diagnostic_tool	334	345	fluorescein
I-Diagnostic_tool	346	357	angiography
O	357	358	.

O	359	361	At
O	362	365	the
O	366	370	time
O	371	373	of
B-Anatomy	374	381	retinal
O	382	389	studies
O	389	390	,
B-Diagnostic_tool	391	397	muscle
I-Diagnostic_tool	398	406	biopsies
O	407	411	also
O	412	416	were
O	417	421	done
O	422	424	to
O	425	432	measure
B-Characteristic	433	442	capillary
I-Characteristic	443	451	basement
I-Characteristic	452	460	membrane
I-Characteristic	461	470	thickness
O	471	472	(
B-Characteristic	472	476	CBMT
O	476	477	)
O	478	480	as
O	481	483	an
O	484	489	index
O	490	492	of
O	493	498	early
B-Symptom	499	512	microvascular
I-Symptom	513	520	changes
I-Symptom	521	523	in
I-Symptom	524	532	skeletal
I-Symptom	533	540	muscles
O	540	541	.

O	542	552	Assessment
O	553	555	of
O	556	564	clinical
O	565	574	metabolic
O	575	582	control
O	582	583	,
O	584	598	interpretation
O	599	601	of
B-Anatomy	602	609	retinal
O	610	618	findings
O	618	619	,
O	620	623	and
B-Characteristic	624	628	CBMT
O	629	633	were
O	634	638	done
O	639	652	independently
O	652	653	.

O	654	656	No
B-Disease	657	668	retinopathy
O	669	672	was
O	673	681	detected
O	682	684	in
O	685	693	patients
O	694	702	observed
O	703	715	continuously
O	716	719	and
O	720	725	known
O	726	728	to
O	729	733	have
O	734	738	been
O	739	741	in
O	742	748	higher
O	749	756	degrees
O	757	759	of
O	760	769	metabolic
O	770	777	control
O	777	778	.

O	779	785	Twenty
O	785	786	-
O	786	790	five
O	791	799	patients
O	800	802	in
O	803	808	lower
O	809	816	degrees
O	817	819	of
O	820	827	control
O	828	831	for
O	832	840	extended
O	841	848	periods
O	849	852	had
B-Disease	853	864	retinopathy
O	864	865	.

B-Characteristic	866	870	CBMT
O	871	874	was
O	875	880	found
O	881	883	to
O	884	886	be
O	887	893	labile
O	894	897	and
O	898	900	to
O	901	909	progress
O	910	912	or
O	913	920	regress
O	921	927	within
O	928	929	a
O	930	934	year
O	935	944	depending
O	945	947	on
O	948	951	the
O	952	958	degree
O	959	961	of
O	962	969	control
O	969	970	.

O	971	974	All
O	975	983	patients
O	984	986	in
O	987	992	lower
O	993	1000	degrees
O	1001	1003	of
O	1004	1011	control
O	1012	1016	with
B-Disease	1017	1028	retinopathy
O	1029	1032	had
O	1033	1042	increased
B-Characteristic	1043	1047	CBMT
O	1047	1048	,
O	1049	1052	but
O	1053	1055	if
O	1056	1060	they
O	1061	1073	subsequently
O	1074	1082	attained
O	1083	1086	and
O	1087	1097	maintained
O	1098	1099	a
O	1100	1104	high
O	1105	1111	degree
O	1112	1114	of
O	1115	1122	control
O	1123	1126	for
O	1127	1128	a
O	1129	1133	year
O	1133	1134	,
O	1135	1139	then
B-Characteristic	1140	1144	CBMT
O	1145	1155	diminished
O	1156	1159	and
O	1160	1165	there
O	1166	1169	was
O	1170	1172	no
O	1173	1184	progression
O	1185	1187	of
B-Disease	1188	1199	retinopathy
O	1199	1200	.

O	1201	1204	Our
O	1205	1210	study
O	1211	1223	demonstrates
O	1224	1228	that
O	1229	1230	a
O	1231	1235	high
O	1236	1242	degree
O	1243	1245	of
O	1246	1255	metabolic
O	1256	1263	control
O	1264	1270	delays
O	1270	1271	,
O	1272	1275	and
O	1276	1279	may
O	1280	1287	prevent
O	1287	1288	,
B-Symptom	1289	1302	microvascular
I-Symptom	1303	1310	changes
O	1310	1311	,
O	1312	1315	and
O	1316	1324	confirms
O	1325	1330	other
O	1331	1338	studies
O	1339	1349	indicating
O	1350	1354	that
O	1355	1359	most
B-Characteristic	1360	1373	postpubescent
O	1373	1374	,
B-Disease	1375	1382	insulin
I-Disease	1382	1383	-
I-Disease	1383	1392	dependent
I-Disease	1393	1401	diabetic
O	1402	1410	patients
O	1411	1415	will
O	1416	1423	develop
B-Disease	1424	1435	retinopathy
O	1436	1442	within
O	1443	1445	15
O	1446	1451	years
O	1452	1458	unless
O	1459	1460	a
O	1461	1471	relatively
O	1472	1476	high
O	1477	1483	degree
O	1484	1486	of
O	1487	1494	control
O	1495	1497	is
O	1498	1508	maintained
O	1508	1509	.
